Apiject Technology
Development Center

Prototype manufacturing and prefilled device development under one roof

The Apiject Technology Development Center, located in the greater Orlando area, is a non-GMP development center that assists pharma companies in designing and creating devices on the Apiject Platform for their drug products.

Wide range of development capabilities

The Technology Development Center assists pharma partners throughout the Apiject development process. This includes:

Machines within the 15,000 sq ft facility include: 

  • Rommelag® 434 BFS machine with Apiject temperature management technology for medium-scale evaluations
  • Weiler® Lab+ BFS machine for small-scale evaluations
  • Hurco® 3-axis milling machine
  • Mold manufacturing and maintenance facility

Easy onramp to assessing injectables for the Apiject Platform

Not sure if your injectable drug product will work in an Apiject device. Whether you want to start with feasibility or progress straight to compatibility, our team can help.

Learn More

Technology Development Center Expert Resources

View All
Apiject Technology Development Center
The ApiJect Technology Development Center in greater Orlando, Florida is focused on helping pharmaceutical companies prepare their drug product for high-speed, high-volume production in a new type of scalable prefilled syringe that is made largely using the Blow-Fill- Seal aseptic process.
ApiJect Announces the Opening of the ApiJect Technology Development Center
New Facility Brings to the U.S. Critical Capabilities for the Design, Engineering and Testing of ApiJect’s High Volume Manufacturing Process for Making Single-Dose, Prefilled Syringes. Stamford, CT., April 13, 2022 — ApiJect Systems, Corp., a medical technology public-benefit corporation that will transform…
ApiJect Announces Proof-of-Concept in Blow-Fill-Seal at Orlando Technology Development Center – Opportunity to “Test Drive” ApiJect Technology –
Orlando, FL, February 28, 2024 – ApiJect Systems, Corp., a medical technology public-benefit corporation, announced it has added product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS)…
Test Drive Our Technology
Apiject has added product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS) using ApiJect prefilled injector technology. Higher volumes may be needed based on the specific requirements…

Related Video Content

View All
Blow-Fill-Seal for Packaging Sterile Liquids, Biologics and Potent Compounds
Did You Know? Drug Stability Testing & Blow-Fill-Seal
Intro to Blow-Fill-Seal / Chapter 11: Manufacturing Footprint

Get in Touch!

Contact us today to learn more about Apiject and easy first steps to see if our Platform may be right for your sterile liquid product.

Contact Us